172 research outputs found
International cooperative study on drug use in pregnancy : results from Malta
The risks of teratogenesis and other adverse effects on the neonate have created a cautious attitude towards the use of drugs during pregnancy. It is generally believed that drug intake in pregnancy is high and variable in different countries, but the quality of prescriptions and use of drugs by the majority of physicians and women has by no means been adequately clarified. To identify the pattern of drug use in pregnancy a collaborative network was set up by WHO - IRO to collect comparable data on a population large enough to represent the current situation across various ’cultural’ and health care settings. This study has shown that, except in the case of the prophylactic administration of haematologicals during the antenatal period and the intrapartum prescriptions to manage labour actively, the majority of pregnant women and health care professionals in Malta have a conservative attitude towards drug prescription in pregnancy and lactation using medications only when they are considered essential.peer-reviewe
MICROCREDIT AND POVERTY ALLEVIATION THROUGH THE LABOUR MARKET: EVIDENCE FROM WOMEN MICROCREDIT CLIENTS IN TANZANIA
Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles
Purpose Heterogeneity has been observed in outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19). Identification of clinical phenotypes may facilitate tailored therapy and improve outcomes. The purpose of this study is to identify specific clinical phenotypes across COVID-19 patients and compare admission characteristics and outcomes. Methods This is a retrospective analysis of COVID-19 patients from March 7, 2020 to August 25, 2020 at 14 U.S. hospitals. Ensemble clustering was performed on 33 variables collected within 72 hours of admission. Principal component analysis was performed to visualize variable contributions to clustering. Multinomial regression models were fit to compare patient comorbidities across phenotypes. Multivariable models were fit to estimate associations between phenotype and in-hospital complications and clinical outcomes. Results The database included 1,022 hospitalized patients with COVID-19. Three clinical phenotypes were identified (I, II, III), with 236 [23.1%] patients in phenotype I, 613 [60%] patients in phenotype II, and 173 [16.9%] patients in phenotype III. Patients with respiratory comorbidities were most commonly phenotype III (p = 0.002), while patients with hematologic, renal, and cardiac (all p<0.001) comorbidities were most commonly phenotype I. Adjusted odds of respiratory, renal, hepatic, metabolic (all p<0.001), and hematological (p = 0.02) complications were highest for phenotype I. Phenotypes I and II were associated with 7.30- fold (HR:7.30, 95% CI:(3.11-17.17), p<0.001) and 2.57-fold (HR:2.57, 95% CI:(1.10-6.00), p = 0.03) increases in hazard of death relative to phenotype III. Conclusion We identified three clinical COVID-19 phenotypes, reflecting patient populations with different comorbidities, complications, and clinical outcomes. Future research is needed to determine the utility of these phenotypes in clinical practice and trial design
The state of the Martian climate
60°N was +2.0°C, relative to the 1981–2010 average value (Fig. 5.1). This marks a new high for the record. The average annual surface air temperature (SAT) anomaly for 2016 for land stations north of starting in 1900, and is a significant increase over the previous highest value of +1.2°C, which was observed in 2007, 2011, and 2015. Average global annual temperatures also showed record values in 2015 and 2016. Currently, the Arctic is warming at more than twice the rate of lower latitudes
Controle das parasitoses gastrintestinais em ovinos e caprinos na região semiárida do Nordeste do Brasil
Denial of long-term issues with agriculture on tropical peatlands will have devastating consequences
Non peer reviewe
- …